The influence of donor characteristics on survival after heart transplantation

C I Tsao1, R J Chen, N K Chou

  • 1Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.

Insights

Donor smoking and need for inotropic support significantly impact heart transplant survival. These factors, alongside recipient data, were analyzed in a retrospective study of 112 heart transplant recipients.

Area of Science:

  • Cardiology
  • Transplantation Immunology
  • Medical Statistics

Background:

  • Heart transplantation (HTx) is a definitive therapy for end-stage heart disease.
  • Donor organ shortage necessitates the use of marginal donors.
  • Donor-related factors' impact on HTx survival requires further investigation.

Purpose of the Study:

  • To identify donor-specific factors influencing long-term survival after primary heart transplantation.
  • To analyze the effect of donor characteristics on post-transplant outcomes in a cohort of 112 recipients.

Main Methods:

  • Retrospective analysis of recipient data from primary HTx between February 2002 and December 2006.
  • Cox regression modeling to assess the influence of donor and recipient variables on survival.
  • Variables included donor demographics, medical history (smoking, hypertension, diabetes, hepatitis), and pre-transplant condition (catecholamines, CPR, CK-MB, troponin I, cold ischemic time).

Main Results:

  • Donor smoking history and the need for inotropic support (catecholamines) were significant negative predictors of post-transplant survival.
  • Donor history of diabetes, hypertension, or hepatitis B/C infection did not significantly affect survival.
  • 88% of donors received inotropic support, and 25% had a history of smoking.

Conclusions:

  • Donor smoking and reliance on inotropic support are critical factors affecting heart transplant recipient survival.
  • Careful consideration of donor history, particularly smoking and hemodynamic support, is essential for optimizing HTx outcomes.
  • Further research may explore strategies to mitigate the risks associated with these donor factors.